Recent developments include Sabra Healthcare reporting Q3 2026 financial results with revenue and FFO exceeding expectations, supported by multiple earnings call transcripts and news articles highlighting operational performance and dividend stability.

• Sabra Healthcare reported Q3 2026 revenue of $249.565 million and net income of $28.607 million, with EPS of $0.11 as per the 10-Q filing dated November 2, 2026 [S2].
• The company announced Q3 FFO and revenue results above expectations in recent news coverage [N1].
• Earnings call transcripts for Q2 and Q1 2026 provide detailed insights into operational performance and strategic initiatives [N3][N7].
• Sabra is recognized for stable dividend payments, with articles noting dividend yields up to 11.5% [N6].

The company demonstrates consistent revenue generation from its healthcare real estate portfolio, supported by stable tenant demand in senior housing and skilled nursing sectors. Its ability to maintain cash flow and earnings per share, as reflected in recent SEC filings and earnings calls, indicates operational stability. Dividend stability and market recognition for yield attractiveness add to its investment profile.

Risks include exposure to regulatory changes in healthcare and senior housing sectors, potential fluctuations in occupancy rates, and sensitivity to interest rate changes affecting REIT financing costs. Market conditions impacting healthcare providers could indirectly affect Sabra's rental income. Limited diversification outside healthcare real estate may increase vulnerability to sector-specific downturns.

Sabra Health Care REIT's moat derives from its specialized focus on healthcare real estate, a niche requiring expertise in regulatory compliance and tenant relationships within the healthcare sector. Its portfolio of senior housing and skilled nursing facilities benefits from demographic trends supporting demand for such properties. The company's established presence and operational scale in this sector contribute to barriers for new entrants.

• Regulatory Risk: Changes in healthcare regulations could impact tenants' operations and Sabra's rental income stability.
• Market and Occupancy Risk: Fluctuations in occupancy rates in senior housing and skilled nursing facilities could affect revenue.
• Interest Rate Risk: Rising interest rates may increase financing costs and pressure profitability.

• Sabra Health Care REIT, Inc. is a real estate investment trust focused on healthcare-related properties.
• The company reported revenue of $249.565 million for the quarter ended September 30, 2026, according to its 10-Q filing [S2].
• Net income for the same period was $28.607 million [S2].
• Basic and diluted earnings per share were both $0.11 for Q3 2026 [S2].
• Cash and cash equivalents totaled $36.24 million as of September 30, 2026 [S2].
• The company has filed its latest quarterly report (10-Q) on November 2, 2026 [S2].
• Sabra Health Care REIT has publicly available earnings call transcripts for Q1, Q2, and Q4 2026, providing insights into operational performance and strategy [N3][N4][N7].
• Recent news coverage highlights that Sabra Healthcare reported Q3 FFO and revenue results above expectations as of November 2, 2026 [N1].
• The company is recognized in the market for stable dividend payments, with mentions in articles discussing dividend yields up to 11.5% [N6].
• Sabra Health Care REIT's business model centers on owning and managing healthcare real estate assets, including senior housing and skilled nursing facilities, as indicated in SEC filings and earnings call transcripts [S1][N3].